Avac Event

Tales from Two Cities: HIV and STI research highlights from Brisbane and Chicago

August 3, 2023 at 9am ET

(Time Converter)

TCA’s invited experts will share their highlights and reflections on the HIV and STI-related science presented at two major global health conferences. These conferences include IAS 2023, taking place in Brisbane, Australia July 23 – 26 and the 2023 STI and HIV World Congress happening in Chicago (United States) from July 24 – July 27.

Speakers include:
Dr. Aniruddha Hazra – University of Chicago
Nyaradzo M Mgodi – University of Zimbabwe
Roger Pebody – NAM, Aidsmap.com
Charlie Peterson – University of Illinois – Chicago

Avac Event

SCOPE Community E-meeting: Developments in the HIV and STIs biomedical prevention pipeline

The European AIDS Treatment Group, along with European and local organizations are coming together for a virtual meeting via Zoom e-meeting on Wednesday, May 24 at 6:00 to 7:30 AM ET (12:00 – 13:30 PM CET).

This interactive e-meeting for community educators and advocates will provide an update on the latest developments in biomedical HIV and STIs prevention research and implementation, new approaches and future challenges. Participants will learn from each other and discuss community preferences, uptake and access issues, as well as advocacy efforts to overcome policy and financial barriers at local, regional and European level. Live interpretation in English and Russian will be provided. This meeting is part of the SCOPE Project.

Avac Event

SCOPE Community E-meeting: Developments in PrEP implementation issues

The European AIDS Treatment Group, along with European and local organizations are coming together for a virtual meeting via Zoom e-meeting on Wednesday, May 24 at 6:00 to 7:30 AM ET (12:00 – 13:30 PM CET).

This interactive e-meeting for community educators and advocates will provide an update on the latest developments and issues in PrEP implementation. Participants will learn from each other and discuss community preferences, uptake and access issues, as well as advocacy efforts to overcome policy and financial barriers at local, regional and European level. Live interpretation in English and Russian will be provided. This meeting is part of the SCOPE Project.

Avac Event

U=U Advocacy Webinar

Because we believe in it, we will advocate for it!

Speakers:

  • Cindra Feuer — Senior Program Manager at AVAC
  • Alice Kayongo — Public health worker in Uganda
  • Winifred Ikilai — National Forum of PLHA Networks Uganda

Time and Login Details
February 11, 2022 from 4-5:30PM CAT/SAST

Join us on Zoom. Meeting ID: 847 9660 1011; passcode: 262309

webinar flyer

Avac Event

HIV Vaccine Awareness Day Webinar Series

This year marks the 25th anniversary of HIV Vaccine Awareness Day. Nothing about HIV vaccine research has ever been easy, and this past year has shown us how difficult this research is, and how essential it continues to be.

Join us for a webinar series this month to mark important milestones in HIV vaccine development and discuss the path forward. The series is chaired by Bill Snow and Stacey Hannah and offers expert perspective on three angles that are critical to vaccine development: Platforms, Processes and Prospects.

Platforms & Pipelines
Wednesday May 18, 2022
The miracle of mRNA: What’s possible beyond SARS-CoV-2—understanding mRNA, its history and potential challenges for HIV vaccines. With Bart Haynes (Duke), Nina Russel (Bill & Melinda Gates Foundation) and Ntando Yola (DTHF).
Recording and Slides: YouTube / Nina Russell’s Slides / Bart Haynes’ Slides

Processes
Tuesday May 24, 2022
The changed landscape of clinical research: the potential for experimental medicine vaccine trials in the current research environment. With Gail Broder (HVTN), Pontiano Kaleebu (MRC-UK) and Robin Shattock (Imperial College).
Recording and Slides: YouTube / Robin Shattock’s Slides / Gail Broder’s Slides / Pontiano Kaleebu’s Slides

Prospects
Tuesday May 31, 2022 @ 10.00am EDT
What have we learned, why it matters and what it means? Understanding recent results in HIV vaccine research and implications for the future. Unpacking results from Uhambo and Imbokodo trials and understanding the implications for the current pipeline of products. With Galit Alter (Harvard), William Kilembe (ZEHRP), Ethel Makila (IAVI) and Dale Hu (NIH).
Recording: YouTube

Avac Event

HVAD 2022 Webinar: Processes

On Tuesday, May 24, 2022, AVAC and partners held Processes, the second webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the changed landscape of clinical research and the potential for experimental medicine vaccine trials in the current research environment.

Moderators:
Panelists:

Recording and Slides: YouTube / Robin Shattock’s Slides / Gail Broder’s Slides / Pontiano Kaleebu’s Slides

Avac Event

HVAD 2022 Webinar: Prospects

On Tuesday, May 31, AVAC and partners held Prospects, the third webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the what we have learned, why it matters and what it means. They looked at recent results in HIV vaccine research and implications for the future, unpacked results from Uhambo and Imbokodo trials and talked about the implications for the current pipeline of products.

Moderators:
Panelists:

Watch the recording here.

Avac Event

HIV Prevention Europe Webinars: Rectal microbicides

The seventh webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on rectal microbicides. The presentation was followed by a Q&A session.

Avac Event

PrEP-ception: Sero-discordant couples using PrEP to reduce HIV transmission risk during pregnancy

The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.

Avac Event

Risky Women: Disrupting simple notions of women’s HIV risk

The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.